A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis

eLife

Volumn 2013, Issue 2, 2013, Pages

  Olive, Virginie ^a   Sabio, Erich ^a   Bennett, Margaux J ^a   De Jong, Caitlin S ^a   Biton, Anne ^a   McGann, James C ^a,h   Greaney, Samantha K ^a   Sodir, Nicole M ^b   Zhou, Alicia Y ^c   Balakrishnan, Asha ^c   Foth, Mona ^a   Luftig, Micah A ^d   Goga, Andrei ^c   Speed, Terence P ^a   Xuan, Zhenyu ^e   Evan, Gerard I ^b   Wan, Ying ^f   Minella, Alex C ^g   He, Lin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

^f THIRD MILITARY MEDICAL UNIVERSITY   (China)

^g NORTHWESTERN UNIVERSITY   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MICRORNA; MICRORNA 17; MICRORNA 92; PROTEIN P53; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CARCINOGENESIS; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FLOW CYTOMETRY; GENE; GENE CONTROL; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; IMMUNOPRECIPITATION; LIVER TUMOR; MICROARRAY ANALYSIS; MIR 17 92 GENE; MOLECULAR CLONING; MOUSE; NONHUMAN; ONCOGENE C MYC; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION; TRANSGENE; TRANSGENIC MOUSE; XENOPUS LAEVIS;

EID: 84885942420     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.00822.001     Document Type: Article

References (58)

1. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, et al. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533-538.doi: 10.1038/318533a0.
2. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-355.doi: 10.1038/nature02871.
3. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.doi: 10.1016/j.cell.2009.01.002.
4. Campaner S, Amati B. 2012. Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance. Cell Div 7:6.doi: 10.1186/1747-1028-7-6.
5. Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM, et al. 2011. miR-17~;92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev 25:1734-1745.doi: 10.1101/gad.17027411.
6. Crusio KM, King B, Reavie LB, Aifantis I. 2010. The ubiquitous nature of cancer: the role of the SCF (Fbw7) complex in development and transformation. Oncogene 29:4865-4873.doi: 10.1038/onc.2010.222.
7. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, Sjoblom T, et al. 2006. The colorectal microRNAome. Proc Natl Acad Sci USA 103:3687-3692.doi:10.1073/pnas.0511155103.
8. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3.doi: 10.1186/gb-2003-4-5-p3.
9. Donnell KAO, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839-843.doi: 10.1038/nature03677.
10. Evan GI, Vousden KH. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature 411:342-348.doi:10.1038/35077213.
11. Filipowicz W, Bhattacharyya SN, Sonenberg N. 2008. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102-114.doi: 10.1038/nrg2290.
12. Gottlieb TM, Leal JFM, Seger R, Taya Y, Oren M. 2002. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 21:1299-1303.doi: 10.1038/sj.onc.1205181.
13. Grim JE, Gustafson M P, Hirata RK, Hagar AC, Swanger J, Welcker M, et al. 2008. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J Cell Biol 181:913-920.doi:10.1083/jcb.200802076.
14. Grim JE, Knoblaugh SE, Guthrie KA, Hagar A, Swanger J, Hespelt J, et al. 2012. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer. Mol Cell Biol 32:2160-2167.doi: 10.1128/MCB.00305-12.
15. Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim L P, Bartel DP. 2007. MicroRNA targeting specifcity in mammals: determinants beyond seed pairing. Mol Cell 27:91-105.doi: 10.1016/j.molcel.2007.06.017.
16. Guil S, Cáceres J F. 2007. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol 14:591-596.doi:10.1038/nsmb1250.
17. He L, He X, Lim L P, de Stanchina E, Xuan Z, Liang Y, et al. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447:1130-1134.doi:10.1038/nature05939.
18. Heasley LE, Hodges RS, Hooper JE, Jones DNM, Lewellyn AL, Maller JL. 2002. Myc suppression of the p21 Cip1 Cdk inhibitor infuences the outcome of the p53 response to DNA damage. Nature 419:729-734.doi: 10.1038/nature01119.
19. Hemann MT, Fridman JS, Zilfou JT, Hernando E, Paddison PJ, Cordon-Cardo C, et al. 2003. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet 33:396-400.doi: 10.1038/ng1091.
20. Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, et al. 2005. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436:807-811.doi: 10.1038/nature03845.
21. Hong L, Lai M, Chen M, Xie C, Liao R, Kang YJ, et al. 2010. The miR-17-92 cluster of microRNAs confers tumorigenic-ity by inhibiting oncogene-induced senescence. Cancer Res 70:8547-8557.doi: 10.1158/0008-5472.CAN-10-1938.
22. Kim VN, Han J, Siomi MC. 2009. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10:126-139.doi: 10.1038/nrm2632.
23. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lübbert H, et al. 1996. Doxycycline-mediated quantitative and tissue-specifc control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93:10933-10938.doi: 10.1073/pnas.93.20.10933.
24. Langdon WY, Harris AW, Cory S, Adams JM. 1986. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47:11-18. doi: 10.1016/0092-8674(86)90361-2.
25. Lewis BP, Shih I, Jones-Rhoades MW, Bartel D P, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115:787-798.doi: 10.1016/S0092-8674(03)01018-3.
26. Lewis BP, Burge CB, Bartel D P. 2005. Conserved seed pairing, often fanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.doi: 10.1016/j.cell.2004.12.035.
27. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song J-J, et al. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305:1437-1441.doi: 10.1126/science.1102513.
28. Lowe SW, Cepero E, Evan G. 2004. Intrinsic tumour suppression. Nature 432:307-315.doi:10.1038/nature03098.
29. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. 2005. MicroRNA expression profles classify human cancers. Nature 435:834-838.doi: 10.1038/nature03702.
30. Lund E, Sheets MD, Imboden SB, Dahlberg JE. 2011. Limiting Ago protein restricts RNAi and microRNA biogenesis during early development in Xenopus laevis. Genes Dev 25:1121-1131.doi:10.1101/gad.2038811.
31. Matsuoka S, Oike Y, Onoyama I, Iwama A, Arai F, Takubo K, et al. 2008. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev 22:986-991.doi: 10.1101/gad.1621808.
32. Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, et al. 2010. Genome-wide RNA-mediated interference screen identifies miR-19 targets in notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 12:372-379.doi:10.1038/ncb2037.
33. Mavrakis KJ, Van Der Meulen J, Wolfe AL, Liu X, Mets E, Taghon T, et al. 2011. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet 43:673-678.doi:10.1038/ng.858.
34. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG. 2007. miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res 35:D149-55.doi: 10.1093/nar/gkl904.
35. Mendell JT. 2008. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133:217-222.doi: 10.1016/j.cell.2008.04.001.
36. Minella AC, Grim JE, Welcker M, Clurman BE. 2007. p53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability. Oncogene 26:6948-6953.doi:10.1038/sj.onc.1210518.
37. Minella AC, Loeb KR, Knecht A, Welcker M, Varnum-Finney BJ, Bernstein ID, et al. 2008. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev 22:1677-1689.doi: 10.1101/gad.1650208.
38. Miranda KC, Huynh T, Tay Y, Ang Y-S, Tam W-L, Thomson AM, et al. 2006. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 126:1203-1217.doi:10.1016/j.cell.2006.07.031.
39. Mu P, Han Y-C, Betel D, Yao E, Squatrito M, Ogrodowski P, et al. 2009. Genetic dissection of the miR-17~;92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23:2806-2811.doi: 10.1101/gad.1872909.
40. Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA, et al. 2008. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14:447-457.doi:10.1016/j.ccr.2008.10.018.
41. Nittner D, Lambertz I, Clermont F, Mestdagh P, Köhler C, Nielsen SJ, et al. 2012. Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation. Nat Cell Biol 14:958-965.doi: 10.1038/ncb2556.
42. Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K, et al. 2002. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 277:21843-21850.doi: 10.1074/jbc.M109745200.
43. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, et al. 2009. miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23:2839-2849.doi:10.1101/gad.1861409.
44. Onoyama I, Tsunematsu R, Matsumoto A, Kimura T, de Alborán IM, Nakayama K, et al. 2007. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 204:2875-2888.doi: 10.1084/jem.20062299.
45. Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM, Lowe SW. 2002. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1:289-298.doi:10.1016/S1535-6108(02)00047-8.
46. Shachaf CM, Kopelman AM, Arvanitis C. 2004. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431:1112-1117.doi: 10.1038/nature03043.
47. Tagawa H, Karube K, Tsuzuki S, Ohshima K, Seto M. 2007. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci 98:1482-1490.doi: 10.1111/j.1349-7006.2007.00531.x.
48. Tanzer A, Stadler P F. 2004. Molecular evolution of a microRNA cluster. J Mol Biol 339:327-335.doi:10.1016/j.jmb.2004.03.065.
49. Tsuchida A, Ohno S, Wu W, Borjigin N, Fujita K, Aoki T, et al. 2011. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 102:2264-2271.doi: 10.1111/j.1349-7006.2011.02081.x.
50. Tusher VG, Tibshirani R, Chu G. 2001. Signifcance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.doi: 10.1073/pnas.091062498.
51. Uziel T, Karginov F V, Xie S, Parker JS, Wang Y-D, Gajjar A, et al. 2009. The miR-17~;92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci USA 106:2812-2817.doi: 10.1073/pnas.0809579106.
52. Walker JC, Harland RM. 2009. microRNA-24a is required to repress apoptosis in the developing neural retina. Genes Dev 23:1046-1051.doi: 10.1101/gad.1777709.
53. Wang Z, Inuzuka H, Zhong J, Wan L, Fukushima H, Sarkar FH, et al. 2012. Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett 586:1409-1418.doi: 10.1016/j.febslet.2012.03.017.
54. Welcker M, Clurman BE. 2008. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8:83-93.doi: 10.1038/nrc2290.
55. Wu Z, Irizarry R, Gentleman R, Murillo FM, Spencer F. 2004. A model based background adjustment for oligonucleotide expression Arrays. Johns Hopkins University, Dept of Biostatistics Working Papers at http://biostats.bepress.com/jhubiostat/paper1.
56. Xu Y, Sengupta T, Kukreja L, Minella AC. 2010. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7. J Biol Chem 285:34439-34446.doi: 10.1074/jbc.M110.152306.
57. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. 2007. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445:656-660.doi: 10.1038/nature05529.
58. Zamore PD, Haley B. 2005. Ribo-gnome: the big world of small RNAs. Science 309:1519-1524.doi: 10.1126/science.1111444.